Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Membrane-spanning 4-domains subfamily A member 15 (MS4A15) is a tetraspanin transmembrane protein localized to the endoplasmic reticulum. It regulates cellular susceptibility to ferroptosis by depleting ER luminal calcium stores and reprogramming lipid metabolism, increasing the abundance of monounsaturated and ether phospholipids that resist oxidative damage. This mechanism provides protection from ferroptosis and supports metabolic adaptation under nutrient stress. MS4A15 is overexpressed in several cancers (notably ovarian cancer), where its high expression is correlated with increased tumor cell proliferation, metabolic reprogramming, and poorer prognosis. Its central role in ferroptosis resistance and metabolic adaptation makes it a promising emerging therapeutic target in cancer biology[1][3][4][7].
Inhibition of ferroptosis through alteration of endoplasmic reticulum calcium homeostasis; Depletion of ER luminal Ca2+ leading to remodeling of membrane phospholipids towards ferroptosis-resistant species
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Membrane-spanning 4-domains subfamily A member 15 (MS4A15).